Annual Total Debt:
$31.26B+$4.91B(+18.64%)Summary
- As of today (April 17, 2025), NVS annual total debt is $31.26 billion, with the most recent change of +$4.91 billion (+18.64%) on December 31, 2024.
- During the last 3 years, NVS annual total debt has risen by +$233.00 million (+0.75%).
- NVS annual total debt is now -17.43% below its all-time high of $37.85 billion, reached on December 31, 2020.
Performance
NVS Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$31.26B-$901.00M(-2.80%)Summary
- As of today (April 17, 2025), NVS quarterly total debt is $31.26 billion, with the most recent change of -$901.00 million (-2.80%) on December 31, 2024.
- Over the past year, NVS quarterly total debt has increased by +$2.27 billion (+7.83%).
- NVS quarterly total debt is now -18.12% below its all-time high of $38.17 billion, reached on September 30, 2020.
Performance
NVS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
NVS Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +7.8% |
| 3 y3 years | +0.8% | +9.5% |
| 5 y5 years | +7.2% | -10.1% |
NVS Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.6% | -2.8% | +24.1% |
| 5 y | 5-year | -17.4% | +18.6% | -18.1% | +24.1% |
| alltime | all time | -17.4% | +732.2% | -18.1% | >+9999.0% |
Novartis AG Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $31.26B(+18.6%) | $31.26B(-2.8%) |
| Sep 2024 | - | $32.16B(+10.9%) |
| Jun 2024 | - | $28.99B(+6.2%) |
| Mar 2024 | - | $27.28B(+3.6%) |
| Dec 2023 | $26.35B(-5.6%) | $26.35B(+4.6%) |
| Sep 2023 | - | $25.19B(-11.1%) |
| Jun 2023 | - | $28.34B(-3.0%) |
| Mar 2023 | - | $29.20B(+4.6%) |
| Dec 2022 | $27.91B(-10.0%) | $27.91B(-2.2%) |
| Sep 2022 | - | $28.54B(-8.2%) |
| Jun 2022 | - | $31.09B(-0.8%) |
| Mar 2022 | - | $31.34B(+1.0%) |
| Dec 2021 | $31.02B(-18.0%) | $31.02B(-9.6%) |
| Sep 2021 | - | $34.33B(-4.2%) |
| Jun 2021 | - | $35.84B(-5.3%) |
| Mar 2021 | - | $37.84B(-0.0%) |
| Dec 2020 | $37.85B(+29.9%) | $37.85B(-0.8%) |
| Sep 2020 | - | $38.17B(+9.7%) |
| Jun 2020 | - | $34.79B(-5.2%) |
| Mar 2020 | - | $36.70B(+25.9%) |
| Dec 2019 | $29.15B(-9.2%) | $29.15B(-3.2%) |
| Sep 2019 | - | $30.12B(-0.5%) |
| Jun 2019 | - | $30.27B(-1.1%) |
| Mar 2019 | - | $30.59B(-4.7%) |
| Dec 2018 | $32.09B(+12.9%) | $32.09B(+1.0%) |
| Sep 2018 | - | $31.78B(-1.8%) |
| Jun 2018 | - | $32.36B(-5.1%) |
| Mar 2018 | - | $34.11B(+20.0%) |
| Dec 2017 | $28.43B(+20.0%) | $28.43B(-5.8%) |
| Sep 2017 | - | $30.16B(-1.3%) |
| Jun 2017 | - | $30.56B(-2.2%) |
| Mar 2017 | - | $31.26B(+32.0%) |
| Dec 2016 | $23.69B(+8.2%) | $23.69B(-10.8%) |
| Sep 2016 | - | $26.57B(+0.8%) |
| Jun 2016 | - | $26.37B(-6.1%) |
| Mar 2016 | - | $28.09B(+28.3%) |
| Dec 2015 | $21.90B(+7.6%) | $21.90B(-3.5%) |
| Sep 2015 | - | $22.70B(-2.5%) |
| Jun 2015 | - | $23.27B(-7.3%) |
| Mar 2015 | - | $25.11B(+23.4%) |
| Dec 2014 | $20.36B(+13.6%) | $20.36B(+3.8%) |
| Sep 2014 | - | $19.61B(-4.0%) |
| Jun 2014 | - | $20.43B(-3.7%) |
| Mar 2014 | - | $21.21B(+18.4%) |
| Dec 2013 | $17.91B(-9.2%) | $17.91B(-4.6%) |
| Sep 2013 | - | $18.77B(-0.5%) |
| Jun 2013 | - | $18.87B(-9.9%) |
| Mar 2013 | - | $20.94B(+6.2%) |
| Dec 2012 | $19.73B | $19.73B(-5.3%) |
| Sep 2012 | - | $20.84B(-7.9%) |
| Jun 2012 | - | $22.63B(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $24.59B(+21.6%) |
| Dec 2011 | $20.23B(-11.8%) | $20.23B(-15.3%) |
| Sep 2011 | - | $23.89B(-13.1%) |
| Jun 2011 | - | $27.50B(-11.6%) |
| Mar 2011 | - | $31.11B(+35.6%) |
| Dec 2010 | $22.94B(+65.0%) | $22.94B(-14.9%) |
| Sep 2010 | - | $26.96B(+44.6%) |
| Jun 2010 | - | $18.64B(+4.0%) |
| Mar 2010 | - | $17.93B(+28.9%) |
| Dec 2009 | $13.91B(+97.7%) | $13.91B(-3.2%) |
| Sep 2009 | - | $14.37B(+3.6%) |
| Jun 2009 | - | $13.87B(+21.1%) |
| Mar 2009 | - | $11.45B(+62.8%) |
| Dec 2008 | $7.04B(+25.8%) | $7.04B(-34.9%) |
| Sep 2008 | - | $10.80B(+0.7%) |
| Jun 2008 | - | $10.73B(+65.6%) |
| Mar 2008 | - | $6.48B(+15.8%) |
| Dec 2007 | $5.59B(-22.5%) | $5.59B(-22.8%) |
| Sep 2007 | - | $7.24B(-2.8%) |
| Jun 2007 | - | $7.45B(+1.4%) |
| Mar 2007 | - | $7.35B(+1.9%) |
| Dec 2006 | $7.22B(-12.1%) | $7.22B(-21.7%) |
| Sep 2006 | - | $9.22B(-2.2%) |
| Jun 2006 | - | $9.43B(+16.5%) |
| Mar 2006 | - | $8.09B(-1.4%) |
| Dec 2005 | $8.21B(+25.2%) | $8.21B(+18.9%) |
| Sep 2005 | - | $6.90B(-10.3%) |
| Jun 2005 | - | $7.69B(+27.2%) |
| Mar 2005 | - | $6.05B(-7.8%) |
| Dec 2004 | $6.56B(+19.9%) | $6.56B(+18.6%) |
| Sep 2004 | - | $5.53B(-7.6%) |
| Jun 2004 | - | $5.99B(-8.5%) |
| Mar 2004 | - | $6.54B(+19.6%) |
| Dec 2003 | $5.47B(+4.4%) | $5.47B(-2.7%) |
| Sep 2003 | - | $5.62B(-19.3%) |
| Jun 2003 | - | $6.97B(+18.6%) |
| Mar 2003 | - | $5.88B(+12.2%) |
| Dec 2002 | $5.24B(+14.7%) | $5.24B(+6.6%) |
| Sep 2002 | - | $4.92B(-2.7%) |
| Jun 2002 | - | $5.05B(>+9900.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $4.57B(+21.6%) | $4.57B(>+9900.0%) |
| Sep 2001 | - | $0.00(-100.0%) |
| Jun 2001 | - | $4.33B(>+9900.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $3.76B(-39.7%) | $3.76B(>+9900.0%) |
| Sep 2000 | - | $0.00(-100.0%) |
| Jun 2000 | - | $5.09B(>+9900.0%) |
| Mar 2000 | - | $0.00 |
| Dec 1999 | $6.23B(-3.8%) | - |
| Dec 1998 | $6.48B | - |
FAQ
- What is Novartis AG annual total debt?
- What is the all time high annual total debt for Novartis AG?
- What is Novartis AG annual total debt year-on-year change?
- What is Novartis AG quarterly total debt?
- What is the all time high quarterly total debt for Novartis AG?
- What is Novartis AG quarterly total debt year-on-year change?
What is Novartis AG annual total debt?
The current annual total debt of NVS is $31.26B
What is the all time high annual total debt for Novartis AG?
Novartis AG all-time high annual total debt is $37.85B
What is Novartis AG annual total debt year-on-year change?
Over the past year, NVS annual total debt has changed by +$4.91B (+18.64%)
What is Novartis AG quarterly total debt?
The current quarterly total debt of NVS is $31.26B
What is the all time high quarterly total debt for Novartis AG?
Novartis AG all-time high quarterly total debt is $38.17B
What is Novartis AG quarterly total debt year-on-year change?
Over the past year, NVS quarterly total debt has changed by +$2.27B (+7.83%)